Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk

Abstract

Allopurinol decreases C-reactive protein and slows down the progression of renal disease in patients with chronic kidney disease. In addition, allopurinol reduces cardiovascular and hospitalization risk in these subjects.